Maternal C-reactive protein and in vitro fertilization (IVF) cycles

J Assist Reprod Genet. 2020 Nov;37(11):2635-2641. doi: 10.1007/s10815-020-01924-1. Epub 2020 Aug 15.

Abstract

Embryo implantation is accompanied by a potent inflammatory response, and a gradient of cytokines and chemokines produced by endometrial cells supports the embryo-endometrial interaction. C-reactive protein (CRP) serves as an early marker of inflammation and recent studies have illustrated that controlled ovarian hyperstimulation (COH) could increase its levels. Interestingly, a high chance of pregnancy has been reported in women who had an elevated CRP level on the day of embryo transfer. It seems an elevated systemic inflammation in the in vitro fertilization (IVF) cycle can increase the implantation and pregnancy rates. However, the results regarding the association of CRP with ART outcomes are controversial. Therefore, in this review, we aimed to describe how CRP levels change during a cycle of IVF treatment and which factors can potentially affect this pattern of change. Furthermore, the association of CRP with ART outcomes has been discussed.

Keywords: ART; Biomarker; CRP; Embryo implantation; Reproductive.

Publication types

  • Review

MeSH terms

  • Adult
  • C-Reactive Protein / genetics*
  • Embryo Implantation
  • Embryo Transfer
  • Endometrium / metabolism
  • Endometrium / pathology
  • Female
  • Fertilization in Vitro*
  • Humans
  • Inflammation / blood*
  • Inflammation / genetics
  • Inflammation / pathology
  • Ovarian Hyperstimulation Syndrome / blood*
  • Ovarian Hyperstimulation Syndrome / genetics
  • Ovarian Hyperstimulation Syndrome / pathology
  • Pregnancy

Substances

  • C-Reactive Protein